ALBEMARLE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.5 USD | -4.01% |
|
-9.94% | -28.36% |
| Jun. 13 | UBS Adjusts Price Target on Albemarle to $124 From $132, Maintains Neutral Rating | MT |
| Jun. 11 | Albemarle Introduces Project Plan for Kings Mountain Mine | MT |
ETFs positioned on Albemarle Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 32 M€ | +3.87% | - | |
| 0.02% | 2 M€ | +3.16% | - | |
| 0.02% | 13 M€ | +21.29% | - | |
| 0.02% | 9 M€ | +9.76% | - | |
| 0.02% | 18 M€ | +5.20% | - | |
| 0.02% | 104 M€ | +5.25% | - | |
| 0.02% | 17 M€ | +3.32% | - | |
| 0.01% | 55 M€ | +2.21% | - | |
| 0.01% | 8 M€ | +0.53% | - | |
| 0.00% | 11 M€ | +1.95% | - | |
| 3.14% | 132 M€ | +10.55% | - | |
| 11.67% | 208 M€ | +13.63% | - |
Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows:
- lithium and polymer solutions (73.6%);
- bromine (15.4%);
- catalysts (11%).
Exports account for 90.3% of net sales.
Sector
Specialty Chemicals
Calendar
2024-07-30
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
103.5
USD
Average target price
152.5
USD
Spread / Average Target
+47.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.36% | 12.17B | |
| +21.02% | 68.55B | |
| -6.50% | 46.06B | |
| +23.31% | 44.48B | |
| +31.85% | 28.5B | |
| +7.56% | 19.22B | |
| -23.96% | 15.27B | |
| -10.29% | 15.22B | |
| -29.56% | 12.12B | |
| +17.54% | 11.06B |
- Stock Market
- Equities
- ALB Stock
- Funds and ETFs Albemarle Corporation
